Skip to content
OVistoaIntelligence index
AboutMethodologyPricingDocs
Sign inSign up
BREAKINGPerson found dead in car after it plows into health club in Portland, Oregon2 hr ago
Top StoriesUnited StatesCanadaWorldPoliticsGeneralBusinessTechHealthSportsAviationArtificial IntelligencePublishers

Closing In On The Elusive

1 articles · 1 outlets · spread 0.00

Closing In On The Elusive
politics21 hr ago

Closing In On The Elusive

Full coverage view across outlets, lean, source quality, and framing. Compare framing without algorithmic ranking.

1 articles1 outletsSpread 0.000 claims
OVistoa

Article-level news analysis, transparent scoring, and API tools for readers, publishers, and teams that need source context.

DMCA and copyright review

Copyright owners can submit notices, counter-notices, and source material concerns through the dedicated review flow.

Open DMCA review

Product

  • Home
  • Feed
  • Search
  • Topics
  • Saved

Platform

  • About
  • Methodology
  • Home
  • Search
  • Saved
  • Me

From the Left

0 outlets

No coverage from this perspective yet.

From the Center

1 outlet
  • The Atlantic

    Closing In On The Elusive

    CLOSING IN ON THE ELUSIVEINSIDE THE RACE AGAINST CANCER Dr. Gregory Friberg is a former clinician who went into oncology when cancer was considered, he says, “a death sentence.” Today, as vice president for global development at Amgen, Friberg is part of a team closing in on once unthinkable gains against cancer, halting tumors long seen as perfectly weaponized against the human body. “I pinch myself almost every day,” says P.K. Morrow, vice president of Global Development at Amgen, “because I can’t believe we are sitting where we are, truly on the cusp of a potential cure for certain cancers.” The subject of almost four decades of research, the RAS gene family are the most frequently mutated oncogenes in human cancers.1, 2 Within this family, KRAS is the most prevalent variant and is particularly common in solid tumors.2 A specific mutation known as KRAS G12C is found in approximately 13% of non-small cell lung cancers, three to five percent of colorectal cancers and one to two percent of numerous other solid tumors.3 Although scientists have understood for decades how KRAS causes cancer, they’ve been unable to do anything about it. Morrow recalls attending a conference only two years ago at

From the Right

0 outlets

No coverage from this perspective yet.

Claim synthesis

Pro users see canonical claims across the cluster and which outlets reported each one.

Learn more

Outlets covering this story

The Atlantic

First seen

Date unavailable

Latest

May 2, 2026

Outlets

1

Diversity

100/100

  • Pricing
  • API docs
  • Publishers

    • Account

    • Sign in
    • Create account
    • Reader settings
    • API console

    Legal

    • Terms
    • Privacy
    • Security
    • DMCA

    © 2026 Vistoa. All rights reserved.

    Limited excerpts, attribution, analysis, and outbound publisher links remain core product boundaries.